Law firms Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business · 1 February 2016 · 1 min read Corporate and M&A Cravath, Swaine & Moore Kirkland & Ellis Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact jasmine.glass@legalbusiness.co.uk Related ContentMore in this categoryRevolving Doors: Weil hires Kirkland secondaries partner as Orrick targets Cadwalader againLaw firmsKate Peacock14 Apr 2026Trading places: Kirkland launches Phildaelphia transactions practice as Sidley hires Cravath ECM partnerLaw firmsWill Lewallen10 Apr 2026Revolving Doors: Simpson Thacher launches in Singapore as Ropes, Clifford Chance build in ParisLaw firmsEliza Winter7 Apr 2026How CMS M&A partner David Roberts became the restaurant expert on both sides of the tableLaw firmsKate Peacock20 Apr 2026‘We’ve got the building blocks in place to grow’ – Harbottle closes in on £60mLaw firmsTom Cox17 Apr 2026Hogan Lovells and Cadwalader partners approve largest ever law firm mergerLaw firmsKate Peacock15 Apr 2026Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesLaw firmsAnna Huntley9 Jan 2025‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryLaw firmsAnna Huntley7 Jan 2025Five partners vie to succeed Hoyland as Simmons managing partnerLaw firmsTom Cox7 Jan 2025